We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$805M
AUM Growth
+$2.82M
Cap. Flow
-$5.52M
Cap. Flow %
-0.69%
Top 10 Hldgs %
21.48%
Holding
266
New
7
Increased
69
Reduced
92
Closed
7

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.49M
2
JAH
JARDEN CORPORATION
JAH
+$861K
3
AGN
Allergan plc
AGN
+$842K
4
LH icon
Labcorp
LH
+$776K
5
ECL icon
Ecolab
ECL
+$712K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.98M
2
AGN
Allergan Inc
AGN
+$1.74M
3
GILD icon
Gilead Sciences
GILD
+$1.33M
4
TFM
THE FRESH MARKET, INC COM STK
TFM
+$1.26M
5
CELG
Celgene Corp
CELG
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 18.07%
2 Industrials 14.98%
3 Miscellaneous 14.57%
4 Technology 12.91%
5 Consumer Staples 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECL icon
26
Ecolab
ECL
$77B
$8.5M 1.06%
74,338
+6,496
+10% +$712K
DLTR icon
27
Dollar Tree
DLTR
$21.2B
$8.47M 1.05%
104,392
+215
+0.2% +$16.3K
NKE icon
28
Nike
NKE
$53.7B
$8.42M 1.05%
167,778
+2,244
+1% +$107K
MON
29
DELISTED
Monsanto Co
MON
$8.33M 1.03%
73,993
+199
+0.3% +$23.7K
TDC icon
30
Teradata
TDC
$2.73B
$8.24M 1.02%
186,679
-3,094
-2% -$135K
ZBRA icon
31
Zebra Technologies
ZBRA
$16.2B
$7.84M 0.97%
86,455
+1,300
+2% +$112K
AFL icon
32
Aflac
AFL
$58.9B
$7.68M 0.95%
239,934
+150
+0.1% +$4.58K
TEVA icon
33
Teva Pharmaceuticals
TEVA
$45.7B
$6.95M 0.86%
111,526
– –
PX
34
DELISTED
Praxair Inc
PX
$6.8M 0.84%
56,293
+100
+0.2% +$12.5K
PH icon
35
Parker-Hannifin
PH
$117B
$6.61M 0.82%
55,624
– –
MMM icon
36
3M
MMM
$84.9B
$6.44M 0.8%
46,689
-264
-0.6% -$36.4K
FRC
37
DELISTED
First Republic Bank
FRC
$6.34M 0.79%
111,072
+3,808
+4% +$207K
PCL
38
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$6.15M 0.76%
141,604
-1,606
-1% -$70K
SYK icon
39
Stryker
SYK
$108B
$6.09M 0.76%
66,050
-675
-1% -$62.8K
DHR icon
40
Danaher
DHR
$147B
$6M 0.74%
105,118
-1,049
-1% -$60.2K
MRK icon
41
Merck
MRK
$355B
$5.92M 0.73%
107,891
+240
+0.2% +$13.6K
VEU icon
42
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$5.81M 0.72%
119,214
+3,931
+3% +$189K
NEE icon
43
NextEra Energy
NEE
$169B
$5.67M 0.7%
217,884
+200
+0.1% +$5.28K
ABBV icon
44
AbbVie
ABBV
$465B
$5.66M 0.7%
96,639
-35
-0% -$2.11K
WAB icon
45
Wabtec
WAB
$47B
$5.52M 0.68%
58,060
+2,125
+4% +$192K
PM icon
46
Philip Morris
PM
$303B
$5.03M 0.63%
66,822
-1,100
-2% -$89.3K
VZ icon
47
Verizon
VZ
$214B
$5.03M 0.62%
103,331
-20
-0% -$965
GLNG icon
48
Golar LNG
GLNG
$5.14B
$5.02M 0.62%
150,748
+2,346
+2% +$75.2K
IBM icon
49
IBM
IBM
$234B
$5M 0.62%
32,602
-1,532
-4% -$232K
AL
50
DELISTED
Air Lease Corp
AL
$4.99M 0.62%
132,319
+1,900
+1% +$69.8K
1
2
3 4 5

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q1 2015 Portfolio in Review

As of Q1 2015, Boston Family Office held 266 positions worth $805M, up 0.35% from $803M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2015 filing shows 7 new, 69 increased, 92 reduced and 7 closed positions. Its largest new stake was Medtronic: 19,713 shares worth $1.54M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.98M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.

  • Boston Family Office's largest Q1 2015 buy was Medtronic: 19,713 shares worth $1.54M.
  • Boston Family Office added most to Allergan plc in Q1 2015, an estimated $842K increase.
  • Boston Family Office's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $1.33M.
  • Boston Family Office fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $1.98M.
  • Boston Family Office's ten largest holdings make up 21% of its $805M portfolio in Q1 2015.
  • Boston Family Office opened 7 new positions and closed 7 in Q1 2015.
  • Boston Family Office's portfolio value rose 0.35% quarter-over-quarter to $805M.

Based on Boston Family Office's 13F filing for Q1 2015, filed 11 May 2015.